Unknown

Dataset Information

0

Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.


ABSTRACT: Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in which P2' residue Leu17 (bovine pancreatic trypsin inhibitor numbering) is mutated to Arg selectively inhibits the active site of plasmin with ?5-fold improved affinity. Thrombin cleavage (24 h extended incubation at a 1:50 enzyme-to-substrate ratio) of the KD1 mutant (Leu17Arg) yielded a smaller molecule containing the intact Kunitz domain with no detectable change in the active-site inhibitory function. The N-terminal sequencing and MALDI-TOF/ESI data revealed that the starting molecule has a C-terminal valine (KD1L17R-VT), whereas the smaller molecule has a C-terminal lysine (KD1L17R-KT). Because KD1L17R-KT has C-terminal lysine, we examined whether it could serve as a decoy receptor for plasminogen/plasmin. Such a molecule might inhibit plasminogen activation as well as the active site of generated plasmin. In surface plasmon resonance experiments, tissue plasminogen activator (tPA) and Glu-plasminogen bound to KD1L17R-KT (Kd ? 0.2 to 0.3 ?M) but not to KD1L17R-VT. Furthermore, KD1L17R-KT inhibited tPA-induced plasma clot fibrinolysis more efficiently than KD1L17R-VT. Additionally, compared to ?-aminocaproic acid KD1L17R-KT was more effective in reducing blood loss in a mouse liver-laceration injury model, where the fibrinolytic system is activated. In further experiments, the micro(?)-plasmin-KD1L17R-KT complex inhibited urokinase-induced plasminogen activation on phorbol-12-myristate-13-acetate-stimulated U937 monocyte-like cells, whereas the ?-plasmin-KD1L17R-VT complex failed to inhibit this process. In conclusion, KD1L17R-KT inhibits the active site of plasmin as well as acts as a decoy receptor for the kringle domain(s) of plasminogen/plasmin; hence, it limits both plasmin generation and activity. With its dual function, KD1L17R-KT could serve as a preferred agent for controlling plasminogen activation in pathological processes.

SUBMITTER: Kumar Y 

PROVIDER: S-EPMC3985851 | biostudies-other | 2014 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

Decoy plasminogen receptor containing a selective Kunitz-inhibitory domain.

Kumar Yogesh Y   Vadivel Kanagasabai K   Schmidt Amy E AE   Ogueli Godwin I GI   Ponnuraj Sathya M SM   Rannulu Nalaka N   Loo Joseph A JA   Bajaj Madhu S MS   Bajaj S Paul SP  

Biochemistry 20140113 3


Kunitz domain 1 (KD1) of tissue factor pathway inhibitor-2 in which P2' residue Leu17 (bovine pancreatic trypsin inhibitor numbering) is mutated to Arg selectively inhibits the active site of plasmin with ∼5-fold improved affinity. Thrombin cleavage (24 h extended incubation at a 1:50 enzyme-to-substrate ratio) of the KD1 mutant (Leu17Arg) yielded a smaller molecule containing the intact Kunitz domain with no detectable change in the active-site inhibitory function. The N-terminal sequencing and  ...[more]

Similar Datasets

| S-EPMC2832096 | biostudies-other
| S-EPMC3190921 | biostudies-literature
| S-EPMC6442024 | biostudies-literature
| S-EPMC3230063 | biostudies-literature
| S-EPMC3180074 | biostudies-literature
| S-EPMC5333494 | biostudies-literature
| S-EPMC3726170 | biostudies-literature
| S-EPMC3751498 | biostudies-literature
| S-EPMC2758390 | biostudies-other
| S-EPMC1951998 | biostudies-literature